| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anti-Bacterial Agents | 16 | 2018 | 142 | 3.810 |
Why?
|
| Drug Utilization | 16 | 2018 | 134 | 2.410 |
Why?
|
| Asthma | 23 | 2010 | 390 | 1.990 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2018 | 392 | 1.870 |
Why?
|
| Parents | 11 | 2018 | 309 | 1.750 |
Why?
|
| Practice Patterns, Physicians' | 14 | 2018 | 350 | 1.700 |
Why?
|
| Child, Preschool | 38 | 2018 | 1478 | 1.470 |
Why?
|
| Child | 46 | 2018 | 2571 | 1.380 |
Why?
|
| Respiratory Tract Infections | 5 | 2016 | 54 | 1.260 |
Why?
|
| Chronic Disease | 7 | 2018 | 468 | 1.130 |
Why?
|
| Adolescent | 32 | 2018 | 3798 | 0.980 |
Why?
|
| Infant | 16 | 2018 | 1245 | 0.970 |
Why?
|
| Medicaid | 13 | 2018 | 211 | 0.900 |
Why?
|
| Male | 42 | 2018 | 10440 | 0.880 |
Why?
|
| Health Education | 5 | 2008 | 115 | 0.820 |
Why?
|
| Female | 43 | 2018 | 13136 | 0.800 |
Why?
|
| Massachusetts | 12 | 2017 | 99 | 0.780 |
Why?
|
| Humans | 52 | 2018 | 18430 | 0.770 |
Why?
|
| Pneumococcal Infections | 3 | 2011 | 53 | 0.760 |
Why?
|
| Anti-Asthmatic Agents | 8 | 2005 | 85 | 0.750 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2012 | 70 | 0.710 |
Why?
|
| Attitude of Health Personnel | 4 | 2018 | 226 | 0.680 |
Why?
|
| Quality of Health Care | 4 | 2018 | 347 | 0.660 |
Why?
|
| United States | 26 | 2018 | 4164 | 0.650 |
Why?
|
| Physicians | 2 | 2018 | 141 | 0.640 |
Why?
|
| Managed Care Programs | 13 | 2008 | 347 | 0.600 |
Why?
|
| Crohn Disease | 2 | 2007 | 16 | 0.590 |
Why?
|
| Inappropriate Prescribing | 2 | 2016 | 9 | 0.590 |
Why?
|
| Transition to Adult Care | 1 | 2017 | 11 | 0.580 |
Why?
|
| Medication Reconciliation | 1 | 2017 | 5 | 0.580 |
Why?
|
| Pediatric Obesity | 1 | 2018 | 80 | 0.580 |
Why?
|
| Emergency Service, Hospital | 3 | 2018 | 382 | 0.550 |
Why?
|
| Critical Care | 1 | 2017 | 73 | 0.540 |
Why?
|
| Patient Readmission | 1 | 2018 | 162 | 0.530 |
Why?
|
| Ambulatory Care | 3 | 2016 | 266 | 0.530 |
Why?
|
| Insurance, Health | 4 | 2014 | 217 | 0.520 |
Why?
|
| Primary Health Care | 6 | 2010 | 848 | 0.500 |
Why?
|
| Multivariate Analysis | 8 | 2017 | 598 | 0.470 |
Why?
|
| Infant, Newborn | 6 | 2018 | 872 | 0.460 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2013 | 15 | 0.460 |
Why?
|
| Pneumococcal Vaccines | 3 | 2009 | 80 | 0.430 |
Why?
|
| Central Nervous System Stimulants | 1 | 2012 | 29 | 0.410 |
Why?
|
| Streptococcus pneumoniae | 1 | 2011 | 25 | 0.390 |
Why?
|
| Adult | 13 | 2018 | 7910 | 0.390 |
Why?
|
| Models, Economic | 1 | 2011 | 22 | 0.380 |
Why?
|
| Health Care Surveys | 6 | 2017 | 247 | 0.370 |
Why?
|
| Health Services Accessibility | 4 | 2010 | 320 | 0.350 |
Why?
|
| Pediatrics | 6 | 2014 | 166 | 0.350 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2009 | 6 | 0.340 |
Why?
|
| Carrier State | 1 | 2009 | 8 | 0.340 |
Why?
|
| Staphylococcal Infections | 1 | 2009 | 15 | 0.340 |
Why?
|
| Medication Adherence | 1 | 2012 | 267 | 0.330 |
Why?
|
| Delivery of Health Care | 2 | 2011 | 444 | 0.330 |
Why?
|
| Drug Resistance, Microbial | 1 | 2008 | 4 | 0.310 |
Why?
|
| Colitis, Ulcerative | 1 | 2007 | 10 | 0.300 |
Why?
|
| Cross-Sectional Studies | 7 | 2018 | 1360 | 0.300 |
Why?
|
| Logistic Models | 6 | 2010 | 962 | 0.300 |
Why?
|
| Pharyngitis | 2 | 2016 | 11 | 0.300 |
Why?
|
| Prospective Studies | 5 | 2017 | 1314 | 0.300 |
Why?
|
| Gastrointestinal Agents | 1 | 2007 | 4 | 0.300 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2004 | 25 | 0.280 |
Why?
|
| Otitis Media | 3 | 2012 | 21 | 0.280 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 214 | 0.280 |
Why?
|
| Hospital Charges | 1 | 2006 | 8 | 0.270 |
Why?
|
| Streptococcus pyogenes | 1 | 2005 | 6 | 0.260 |
Why?
|
| Focus Groups | 2 | 2018 | 154 | 0.260 |
Why?
|
| Young Adult | 4 | 2018 | 2518 | 0.260 |
Why?
|
| Streptococcal Infections | 1 | 2005 | 22 | 0.260 |
Why?
|
| Outcome and Process Assessment (Health Care) | 2 | 2004 | 110 | 0.260 |
Why?
|
| Quality Assurance, Health Care | 2 | 2008 | 188 | 0.260 |
Why?
|
| Drug Prescriptions | 4 | 2008 | 157 | 0.250 |
Why?
|
| Hospitalization | 5 | 2007 | 847 | 0.250 |
Why?
|
| Macrolides | 1 | 2004 | 8 | 0.250 |
Why?
|
| Cluster Analysis | 4 | 2009 | 96 | 0.240 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2005 | 254 | 0.230 |
Why?
|
| Middle Aged | 8 | 2018 | 8284 | 0.230 |
Why?
|
| Otitis | 1 | 2003 | 1 | 0.230 |
Why?
|
| Data Collection | 3 | 2014 | 275 | 0.220 |
Why?
|
| Severity of Illness Index | 5 | 2010 | 476 | 0.210 |
Why?
|
| Total Quality Management | 1 | 2002 | 27 | 0.210 |
Why?
|
| Air Pollution, Indoor | 1 | 2002 | 7 | 0.200 |
Why?
|
| Retrospective Studies | 6 | 2018 | 2550 | 0.200 |
Why?
|
| Attitude to Health | 1 | 2003 | 177 | 0.200 |
Why?
|
| Hospitals, Pediatric | 2 | 2017 | 80 | 0.200 |
Why?
|
| Environmental Exposure | 1 | 2002 | 115 | 0.190 |
Why?
|
| Risk Factors | 5 | 2011 | 3449 | 0.190 |
Why?
|
| Incidence | 4 | 2011 | 1314 | 0.180 |
Why?
|
| Age Distribution | 3 | 2018 | 261 | 0.180 |
Why?
|
| Interviews as Topic | 2 | 2018 | 327 | 0.160 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 36 | 0.160 |
Why?
|
| Prevalence | 3 | 2016 | 911 | 0.160 |
Why?
|
| Hospitals, High-Volume | 1 | 2018 | 2 | 0.160 |
Why?
|
| Maryland | 1 | 2018 | 15 | 0.160 |
Why?
|
| New York | 1 | 2018 | 22 | 0.160 |
Why?
|
| Risk | 2 | 2018 | 552 | 0.150 |
Why?
|
| Risk Assessment | 4 | 2008 | 1143 | 0.150 |
Why?
|
| Confidence Intervals | 4 | 2008 | 253 | 0.150 |
Why?
|
| Family Practice | 3 | 2008 | 53 | 0.150 |
Why?
|
| Urban Population | 1 | 2018 | 124 | 0.150 |
Why?
|
| Near Miss, Healthcare | 1 | 2017 | 1 | 0.150 |
Why?
|
| Medication Errors | 1 | 2017 | 7 | 0.150 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2017 | 15 | 0.140 |
Why?
|
| Otitis Media, Suppurative | 1 | 2016 | 1 | 0.140 |
Why?
|
| Odds Ratio | 4 | 2008 | 701 | 0.140 |
Why?
|
| Time Factors | 2 | 2018 | 1136 | 0.130 |
Why?
|
| Models, Statistical | 1 | 2017 | 185 | 0.130 |
Why?
|
| Overweight | 1 | 2018 | 276 | 0.130 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 228 | 0.130 |
Why?
|
| Health Services | 2 | 2007 | 117 | 0.130 |
Why?
|
| Cohort Studies | 8 | 2018 | 2672 | 0.120 |
Why?
|
| Education, Medical, Continuing | 2 | 2005 | 31 | 0.120 |
Why?
|
| Age Factors | 3 | 2008 | 965 | 0.120 |
Why?
|
| Computer Communication Networks | 1 | 2014 | 18 | 0.120 |
Why?
|
| Midwestern United States | 1 | 2014 | 4 | 0.120 |
Why?
|
| New England | 1 | 2014 | 13 | 0.120 |
Why?
|
| Northwestern United States | 1 | 2014 | 58 | 0.120 |
Why?
|
| Medicine, Traditional | 1 | 2013 | 4 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2005 | 72 | 0.110 |
Why?
|
| Watchful Waiting | 1 | 2013 | 18 | 0.110 |
Why?
|
| Aged | 4 | 2016 | 6417 | 0.110 |
Why?
|
| Influenza Vaccines | 2 | 2006 | 290 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2012 | 10 | 0.100 |
Why?
|
| Educational Status | 2 | 2003 | 205 | 0.100 |
Why?
|
| Continental Population Groups | 2 | 2006 | 315 | 0.100 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 2 | 2009 | 22 | 0.100 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 197 | 0.100 |
Why?
|
| Socioeconomic Factors | 3 | 2010 | 673 | 0.100 |
Why?
|
| Office Visits | 3 | 2008 | 86 | 0.100 |
Why?
|
| Sinusitis | 1 | 2011 | 14 | 0.090 |
Why?
|
| Probability | 2 | 2008 | 86 | 0.090 |
Why?
|
| Group Practice | 2 | 2008 | 26 | 0.090 |
Why?
|
| Inpatients | 1 | 2011 | 80 | 0.090 |
Why?
|
| Outpatients | 1 | 2011 | 111 | 0.090 |
Why?
|
| Sepsis | 1 | 2011 | 71 | 0.090 |
Why?
|
| Nasal Cavity | 1 | 2009 | 2 | 0.090 |
Why?
|
| Regression Analysis | 2 | 2007 | 319 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2008 | 1269 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2011 | 251 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2010 | 136 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 232 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2014 | 747 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 35 | 0.080 |
Why?
|
| Amoxicillin | 1 | 2008 | 3 | 0.080 |
Why?
|
| Treatment Failure | 1 | 2008 | 36 | 0.080 |
Why?
|
| Reference Values | 1 | 2008 | 93 | 0.080 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 95 | 0.080 |
Why?
|
| Mesalamine | 1 | 2007 | 1 | 0.070 |
Why?
|
| Prednisolone | 1 | 2007 | 3 | 0.070 |
Why?
|
| Infliximab | 1 | 2007 | 8 | 0.070 |
Why?
|
| Health Maintenance Organizations | 3 | 2006 | 479 | 0.070 |
Why?
|
| Canada | 1 | 2007 | 67 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 21 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2007 | 27 | 0.070 |
Why?
|
| Qualitative Research | 1 | 2008 | 272 | 0.070 |
Why?
|
| Teratogens | 1 | 2006 | 3 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2006 | 333 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2008 | 365 | 0.070 |
Why?
|
| Drug Therapy | 1 | 2006 | 21 | 0.070 |
Why?
|
| Mass Media | 1 | 2006 | 17 | 0.070 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 17 | 0.070 |
Why?
|
| Influenza, Human | 2 | 2006 | 282 | 0.060 |
Why?
|
| Sex Factors | 1 | 2008 | 661 | 0.060 |
Why?
|
| Peer Group | 1 | 2005 | 48 | 0.060 |
Why?
|
| Policy Making | 1 | 2005 | 18 | 0.060 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2005 | 4 | 0.060 |
Why?
|
| Surveys and Questionnaires | 3 | 2006 | 1389 | 0.060 |
Why?
|
| Registries | 1 | 2007 | 490 | 0.060 |
Why?
|
| Health Surveys | 1 | 2005 | 269 | 0.060 |
Why?
|
| Physicians, Family | 1 | 2004 | 47 | 0.060 |
Why?
|
| Cultural Diversity | 1 | 2004 | 17 | 0.060 |
Why?
|
| Vaccines, Conjugate | 1 | 2004 | 66 | 0.060 |
Why?
|
| Vaccination | 2 | 2006 | 674 | 0.060 |
Why?
|
| Immunization Programs | 1 | 2004 | 68 | 0.060 |
Why?
|
| Meningococcal Vaccines | 1 | 2004 | 46 | 0.060 |
Why?
|
| Process Assessment (Health Care) | 1 | 2003 | 28 | 0.060 |
Why?
|
| Research Design | 2 | 2004 | 402 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2003 | 167 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2004 | 162 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2003 | 100 | 0.050 |
Why?
|
| Linear Models | 1 | 2003 | 243 | 0.050 |
Why?
|
| Ethnic Groups | 2 | 2006 | 501 | 0.050 |
Why?
|
| Chicago | 1 | 2002 | 27 | 0.050 |
Why?
|
| Boston | 1 | 2002 | 37 | 0.050 |
Why?
|
| Efficiency, Organizational | 1 | 2002 | 36 | 0.050 |
Why?
|
| Case Management | 1 | 2002 | 37 | 0.050 |
Why?
|
| Minority Groups | 1 | 2002 | 105 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 321 | 0.050 |
Why?
|
| Washington | 1 | 2002 | 388 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2002 | 244 | 0.050 |
Why?
|
| Pregnancy | 1 | 2006 | 1516 | 0.050 |
Why?
|
| Child Health Services | 1 | 2002 | 129 | 0.050 |
Why?
|
| Health Behavior | 1 | 2003 | 374 | 0.050 |
Why?
|
| Patient Selection | 1 | 2002 | 198 | 0.050 |
Why?
|
| Community Health Centers | 1 | 2002 | 112 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2003 | 318 | 0.050 |
Why?
|
| Mass Screening | 1 | 2006 | 690 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 760 | 0.040 |
Why?
|
| Body Height | 1 | 2018 | 62 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2008 | 1296 | 0.040 |
Why?
|
| Body Weight | 1 | 2018 | 223 | 0.040 |
Why?
|
| Steroids | 2 | 2007 | 15 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2007 | 86 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 724 | 0.030 |
Why?
|
| Vocabulary, Controlled | 1 | 2014 | 1 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2014 | 44 | 0.030 |
Why?
|
| State Health Plans | 2 | 2004 | 44 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2014 | 57 | 0.030 |
Why?
|
| Administration, Inhalation | 2 | 2004 | 37 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2018 | 974 | 0.030 |
Why?
|
| Poverty | 2 | 2003 | 182 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2008 | 20 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 100 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 131 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2008 | 198 | 0.020 |
Why?
|
| Acute Disease | 1 | 2008 | 144 | 0.020 |
Why?
|
| Recurrence | 1 | 2008 | 187 | 0.020 |
Why?
|
| Health Services Administration | 1 | 2007 | 6 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2007 | 47 | 0.020 |
Why?
|
| Health Policy | 1 | 2008 | 136 | 0.020 |
Why?
|
| Caregivers | 1 | 2007 | 126 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 106 | 0.020 |
Why?
|
| Korea | 1 | 2005 | 9 | 0.020 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2005 | 20 | 0.020 |
Why?
|
| Child Welfare | 1 | 2004 | 40 | 0.010 |
Why?
|
| Poisson Distribution | 1 | 2004 | 94 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2004 | 71 | 0.010 |
Why?
|
| Utilization Review | 1 | 2004 | 56 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2004 | 33 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 270 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2004 | 160 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2006 | 346 | 0.010 |
Why?
|
| Vulnerable Populations | 1 | 2003 | 47 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2004 | 108 | 0.010 |
Why?
|
| Health Services Research | 1 | 2004 | 264 | 0.010 |
Why?
|
| Disease Management | 1 | 2003 | 143 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2002 | 15 | 0.010 |
Why?
|
| Private Practice | 1 | 2002 | 15 | 0.010 |
Why?
|
| Fee-for-Service Plans | 1 | 2002 | 28 | 0.010 |
Why?
|
| Communication | 1 | 2003 | 202 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2002 | 197 | 0.010 |
Why?
|
| Health Status | 1 | 2002 | 328 | 0.010 |
Why?
|
| Hispanic Americans | 1 | 2002 | 428 | 0.010 |
Why?
|
| European Continental Ancestry Group | 1 | 2002 | 554 | 0.010 |
Why?
|
| African Americans | 1 | 2002 | 490 | 0.010 |
Why?
|